TY - JOUR
T1 - A genomewide scan for early-onset coronary artery disease in 438 families
T2 - The GENECARD study
AU - Hauser, Elizabeth R.
AU - Crossman, David C.
AU - Granger, Christopher B.
AU - Haines, Jonathan L.
AU - Jones, Christopher J.H.
AU - Mooser, Vincent
AU - McAdam, Brendan
AU - Winkelmann, Bernhard R.
AU - Wiseman, Alan H.
AU - Muhlestein, J. Brent
AU - Bartel, Alan G.
AU - Dennis, Charles A.
AU - Dowdy, Elaine
AU - Estabrooks, Susan
AU - Eggleston, Karen
AU - Francis, Sheila
AU - Roche, Kath
AU - Clevenger, Paula W.
AU - Huang, Liling
AU - Pedersen, Bonnie
AU - Shah, Svati
AU - Schmidt, Silke
AU - Haynes, Carol
AU - West, Sandra
AU - Asper, Donny
AU - Booze, Michael
AU - Sharma, Sanjay
AU - Sundseth, Scott
AU - Middleton, Lefkos
AU - Roses, Allen D.
AU - Hauser, Michael A.
AU - Vance, Jeffery M.
AU - Pericak-Vance, Margaret A.
AU - Kraus, William E.
N1 - Funding Information:
We gratefully acknowledge the participation and enthusiasm of the families who gave their DNA samples for this work, and we thank the medical caregivers who helped us collect the primary data sources (Hauser et al. 2003 ). We are grateful for the assistance of staff members at each of the clinical collection sites, GlaxoSmithKline, and the Center for Human Genetics at Duke University. This work was supported by contracts to the participating institutions from GlaxoSmithKline and by grants from the National Institutes of Health (HL073389 and MH059528 [to E.R.H.]).
PY - 2004/9
Y1 - 2004/9
N2 - A family history of coronary artery disease (CAD), especially when the disease occurs at a young age, is a potent risk factor for CAD. DNA collection in families in which two or more siblings are affected at an early age allows identification of genetic factors for CAD by linkage analysis. We performed a genomewide scan in 1,168 individuals from 438 families, including 493 affected sibling pairs with documented onset of CAD before 51 years of age in men and before 56 years of age in women. We prospectively defined three phenotypic subsets of families: (1) acute coronary syndrome in two or more siblings; (2) absence of type 2 diabetes in all affected siblings; and (3) atherogenic dyslipidemia in any one sibling. Genotypes were analyzed for 395 microsatellite markers. Regions were defined as providing evidence for linkage if they provided parametric two-point LOD scores >1.5, together with nonparametric multipoint LOD scores >1.0. Regions on chromosomes 3q13 (multipoint LOD = 3.3; empirical P value <.001) and 5q31 (multipoint LOD = 1.4; empirical P value <.081) met these criteria in the entire data set, and regions on chromosomes 1q25, 3q13, 7p14, and 19p13 met these criteria in one or more of the subsets. Two regions, 3q13 and 1q25, met the criteria for genomewide significance. We have identified a region on chromosome 3q13 that is linked to early-onset CAD, as well as additional regions of interest that will require further analysis. These data provide initial areas of the human genome where further investigation may reveal susceptibility genes for early-onset CAD.
AB - A family history of coronary artery disease (CAD), especially when the disease occurs at a young age, is a potent risk factor for CAD. DNA collection in families in which two or more siblings are affected at an early age allows identification of genetic factors for CAD by linkage analysis. We performed a genomewide scan in 1,168 individuals from 438 families, including 493 affected sibling pairs with documented onset of CAD before 51 years of age in men and before 56 years of age in women. We prospectively defined three phenotypic subsets of families: (1) acute coronary syndrome in two or more siblings; (2) absence of type 2 diabetes in all affected siblings; and (3) atherogenic dyslipidemia in any one sibling. Genotypes were analyzed for 395 microsatellite markers. Regions were defined as providing evidence for linkage if they provided parametric two-point LOD scores >1.5, together with nonparametric multipoint LOD scores >1.0. Regions on chromosomes 3q13 (multipoint LOD = 3.3; empirical P value <.001) and 5q31 (multipoint LOD = 1.4; empirical P value <.081) met these criteria in the entire data set, and regions on chromosomes 1q25, 3q13, 7p14, and 19p13 met these criteria in one or more of the subsets. Two regions, 3q13 and 1q25, met the criteria for genomewide significance. We have identified a region on chromosome 3q13 that is linked to early-onset CAD, as well as additional regions of interest that will require further analysis. These data provide initial areas of the human genome where further investigation may reveal susceptibility genes for early-onset CAD.
UR - http://www.scopus.com/inward/record.url?scp=4143098058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4143098058&partnerID=8YFLogxK
U2 - 10.1086/423900
DO - 10.1086/423900
M3 - Article
C2 - 15272420
AN - SCOPUS:4143098058
SN - 0002-9297
VL - 75
SP - 436
EP - 447
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -